Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-20

Clinical Trial Update: Study of MRgFUS Exablate Treatment Following the Neuropathic Pain [NA]

View source ↗

Summary

The study evaluating MR-guided focused ultrasound Exablate treatment for neuropathic pain has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exablate MRgFUS (MR-guided focused ultrasound)

Snippet

Sponsor: InSightec | Conditions: Neuropathic Pain | NA | Status: TERMINATED